期刊文献+

血液灌流串联血液透析滤过改善尿毒症并发甲状旁腺功能亢进 被引量:16

Clinical Observation of Improving Uremia Combined with Hyperparathyroidism by Treatment of Hemoperfusion Series Coupling Hemodiafiltration
下载PDF
导出
摘要 目的探讨血液灌流(hemoperfusion,HP)串联血液透析滤过(hemodiafiltration,HDF)对改善尿毒症并发甲状旁腺功能亢进(甲旁亢)的疗效。方法将慢性肾功能衰竭尿毒症继发性甲旁亢60例随机分为A、B两组。A组行高通量透析,B组行HP串联HDF,分别于首次治疗前后及治疗12周前后测定甲状旁腺素(PTH)、血尿素(blood urea nitrogen,BUN)、血肌酐(serum creatinine,SCr)、血清钙(calcium,Ca2+)、血磷(phosphorus,P3+)、血红蛋白(Hb)、红细胞压积(HCT)、血压及促红素用量,观察两组改善继发性甲旁亢各指标的效果。结果两组患者首次治疗前PTH、Hb、HCT、BUN、SCr、Ca2+、P3+、促红素第1周用量、血压等比较差异均无统计学意义(P>0.05);首次治疗后PTH、肾功能比较差异有统计学意义(P<0.05);末次治疗前PTH、Hb、HCT、BUN、SCr、Ca2+、P3+、促红素第12周用量、血压等比较差异有统计学意义(P<0.05);末次治疗后PTH比较差异有统计学意义(P<0.05)。结论 HP串联HDF能有效改善尿毒症继发性甲旁亢各项指标。 Objective To discuss the curative effect of improvement of uremia combined with hyperparathyroidism by hemoperfusion (HP) series coupling hemodiafiltration (HDF) treatment. Methods Sixty patients with uremia combined with secondary hyperparathyroidism during August 2008 and August 2011 were randomly divided into group A and group B. Group A was treated with high-flux hemodialysis (HF- HD) ; while group B was treated with hemoperfusion (HP) series coupling hemodiafihration (HDF). The parathyroid hormone (PTH), blood urea nitrogen (BUN), serum creatinine (SCr), serum calcium (Ca^2+), phosphorus (P^3+), hemoglobin (Hb), hematocrit (HCT), blood pressure and erythropoietin dosage of the two groups were detected before and after the first treatment, and at thel2th week after treatment. Indexes of improving secondary hyperparathyroidism of the two groups were also observed. Results The differences of the two groups were not statistically significant in PTH, Hb, HCT, BUN, SCr, Ca^2+ , P^3+ , the first week dose of erythropoietin and bk,3d pressure (P 〉0.06) ; After first treatment, the differences were statistically significant in FFH and renal function (P 〈0. 06); Before the last treatment there were statistically significant in PTH, Hb, HCT, BUN, SCr, Ca^2+ , P^3 + , the 12th week dose of erythropoietin and blood pressure (P 〈 0. 06) ; After the last treatment the difference in PTH was statistically significant (P 〈0. 06). Conclusion The method of HP series coupling HDF e, an eftectively improve indexes of uremia combined with secondaLw hyperparathyroidism.
出处 《临床误诊误治》 2013年第2期89-93,共5页 Clinical Misdiagnosis & Mistherapy
关键词 血液灌流 血液透析滤过 高通量血液透析 尿毒症 甲状旁腺功能亢进 Hemoperfusion Hemodiafil ration High-flux bemodialysis Uremia Hyperparathyroidism
  • 相关文献

参考文献15

  • 1陈靖;王笑云;陈楠.慢性透析患者并发症[A]北京:北京科学技术出版社,2010743-856.
  • 2安书强,杨倩,贾晓娟,张晓磊.慢性肾功能衰竭血液灌流串联血液透析滤过清除瘦素、甲状旁腺素效果研究[J].武警医学,2011,22(4):284-286. 被引量:9
  • 3柯剑婷,朱伟平,陈剑,陈家湄,李杰,杜艺,李宓.尿毒症继发性甲旁亢甲状旁腺切除术临床观察[J].中国实用医药,2009,4(29):17-19. 被引量:10
  • 4Horl W H. The clinical consequences of secondary hyperparathyroidism:focus on clinical outcomes[J].Nephrology Dialysis Transplantation,2004,(Suppl 5):V2-V8.
  • 5Covic A,Kothawala P,Bernal M. Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality,cardiovascular mortality and cardiovascular events in chronic kidney disease[J].Nephrology Dialysis Transplantation,2009,(05):1506-1523.
  • 6Weinreich T. Low or High calcium dialysate solutions in peritoneal dialysis[J].Kidney International,2006,(Suppl):S92-S96.
  • 7Izquierdo A,López-Luna P,Ortega A. The parathyroid hormonerelated protein system and diabetic nephropathy outcome in streptozotocin-induced diabetes[J].Kidney International,2006,(12):2171-2177.
  • 8马腾,赵学智,梅长林.骨化三醇治疗慢性肾病继发性甲状旁腺功能亢进疗效观察[J].中国中西医结合肾病杂志,2008,9(2):143-145. 被引量:21
  • 9Brancaccio D,Cozzolino M,Gallieni M. Hyperparathyroidism and anemia in uremic subjects:a combined therapeutic approach[J].Journal of the American Society of Nephrology,2004,(Suppl 1):S21-S2A.
  • 10Campese V M,Park J. The kidney and hypertension:over 70 years of research[J].Journal of Nephrology,2006,(06):691-698.

二级参考文献51

共引文献47

同被引文献146

引证文献16

二级引证文献93

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部